Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.12
CHE's Cash-to-Debt is ranked lower than
70% of the 274 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. CHE: 0.12 )
Ranked among companies with meaningful Cash-to-Debt only.
CHE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.16 Max: 2.78
Current: 0.12
0
2.78
Equity-to-Asset 0.60
CHE's Equity-to-Asset is ranked higher than
67% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. CHE: 0.60 )
Ranked among companies with meaningful Equity-to-Asset only.
CHE' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.51 Max: 0.61
Current: 0.6
0.31
0.61
Debt-to-Equity 0.19
CHE's Debt-to-Equity is ranked higher than
84% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. CHE: 0.19 )
Ranked among companies with meaningful Debt-to-Equity only.
CHE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13  Med: 0.4 Max: 1.17
Current: 0.19
0.13
1.17
Debt-to-EBITDA 0.39
CHE's Debt-to-EBITDA is ranked higher than
84% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. CHE: 0.39 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CHE' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.39  Med: 0.91 Max: 1.09
Current: 0.39
0.39
1.09
Interest Coverage 47.17
CHE's Interest Coverage is ranked higher than
69% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 6.85 vs. CHE: 47.17 )
Ranked among companies with meaningful Interest Coverage only.
CHE' s Interest Coverage Range Over the Past 10 Years
Min: 9.2  Med: 11.69 Max: 50.65
Current: 47.17
9.2
50.65
Piotroski F-Score: 7
Altman Z-Score: 12.24
Beneish M-Score: -2.36
WACC vs ROIC
10.57%
32.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 13.35
CHE's Operating Margin % is ranked higher than
50% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.83 vs. CHE: 13.35 )
Ranked among companies with meaningful Operating Margin % only.
CHE' s Operating Margin % Range Over the Past 10 Years
Min: 9.79  Med: 11.58 Max: 13.35
Current: 13.35
9.79
13.35
Net Margin % 11.00
CHE's Net Margin % is ranked higher than
61% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.88 vs. CHE: 11.00 )
Ranked among companies with meaningful Net Margin % only.
CHE' s Net Margin % Range Over the Past 10 Years
Min: 5.46  Med: 6.29 Max: 11
Current: 11
5.46
11
ROE % 37.47
CHE's ROE % is ranked higher than
82% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 8.03 vs. CHE: 37.47 )
Ranked among companies with meaningful ROE % only.
CHE' s ROE % Range Over the Past 10 Years
Min: 16.88  Med: 19.05 Max: 37.47
Current: 37.47
16.88
37.47
ROA % 20.80
CHE's ROA % is ranked higher than
84% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. CHE: 20.80 )
Ranked among companies with meaningful ROA % only.
CHE' s ROA % Range Over the Past 10 Years
Min: 8.79  Med: 10.69 Max: 20.8
Current: 20.8
8.79
20.8
ROC (Joel Greenblatt) % 161.20
CHE's ROC (Joel Greenblatt) % is ranked higher than
87% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 14.91 vs. CHE: 161.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CHE' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 91.69  Med: 170.4 Max: 190.39
Current: 161.2
91.69
190.39
3-Year Revenue Growth Rate 6.80
CHE's 3-Year Revenue Growth Rate is ranked higher than
53% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. CHE: 6.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CHE' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -19.5  Med: 8 Max: 42.9
Current: 6.8
-19.5
42.9
3-Year EBITDA Growth Rate -6.10
CHE's 3-Year EBITDA Growth Rate is ranked lower than
78% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. CHE: -6.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CHE' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.2  Med: 9.8 Max: 72.9
Current: -6.1
-35.2
72.9
3-Year EPS without NRI Growth Rate 1.70
CHE's 3-Year EPS without NRI Growth Rate is ranked lower than
64% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. CHE: 1.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CHE' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 10.8 Max: 59.5
Current: 1.7
0
59.5
GuruFocus has detected 2 Warning Signs with Chemed Corp CHE.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CHE's 30-Y Financials

Financials (Next Earnings Date: 2018-10-26)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

CHE Guru Trades in Q3 2017

Jim Simons 106,300 sh (+50.99%)
Caxton Associates 2,732 sh (unchged)
Ken Fisher 496,254 sh (-0.89%)
Chuck Royce 20,008 sh (-4.05%)
Mario Gabelli 527,204 sh (-5.26%)
Jeremy Grantham 16,807 sh (-34.87%)
Joel Greenblatt 18,034 sh (-43.08%)
» More
Q4 2017

CHE Guru Trades in Q4 2017

Leucadia National 1,386 sh (New)
Columbia Wanger 36,214 sh (New)
Caxton Associates Sold Out
Joel Greenblatt Sold Out
Ken Fisher 491,004 sh (-1.06%)
Chuck Royce 19,324 sh (-3.42%)
Mario Gabelli 497,170 sh (-5.70%)
Jim Simons 54,400 sh (-48.82%)
Jeremy Grantham 2,000 sh (-88.10%)
» More
Q1 2018

CHE Guru Trades in Q1 2018

Leucadia National 5,046 sh (+264.07%)
Jim Simons 71,600 sh (+31.62%)
Chuck Royce 19,324 sh (unchged)
Jeremy Grantham 2,000 sh (unchged)
Ken Fisher 481,379 sh (-1.96%)
Mario Gabelli 428,301 sh (-13.85%)
» More
Q2 2018

CHE Guru Trades in Q2 2018

Steven Cohen 76,400 sh (New)
Joel Greenblatt 1,727 sh (New)
Caxton Associates 2,152 sh (New)
Paul Tudor Jones 13,197 sh (New)
Pioneer Investments 2,689 sh (New)
Jim Simons 137,900 sh (+92.60%)
Chuck Royce 19,324 sh (unchged)
Leucadia National Sold Out
Jeremy Grantham Sold Out
Ken Fisher 479,676 sh (-0.35%)
Mario Gabelli 282,230 sh (-34.10%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:CHE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2018-06-30 Reduce -0.35%$268.07 - $333.26 $ 295.53-5%479,676
Mario Gabelli 2018-06-30 Reduce -34.10%0.27%$268.07 - $333.26 $ 295.53-5%282,230
Joel Greenblatt 2018-06-30 New Buy0.01%$268.07 - $333.26 $ 295.53-5%1,727
Leucadia National 2018-06-30 Sold Out 0.1%$268.07 - $333.26 $ 295.53-5%0
Ken Fisher 2018-03-31 Reduce -1.96%$243.02 - $281.47 $ 295.5312%481,379
Mario Gabelli 2018-03-31 Reduce -13.85%0.11%$243.02 - $281.47 $ 295.5312%428,301
Leucadia National 2018-03-31 Add 264.07%0.07%$243.02 - $281.47 $ 295.5312%5,046
Mario Gabelli 2017-12-31 Reduce -5.70%0.04%$199.69 - $247.53 $ 295.5330%497,170
Ken Fisher 2017-12-31 Reduce -1.06%$199.69 - $247.53 $ 295.5330%491,004
Leucadia National 2017-12-31 New Buy0.03%$199.69 - $247.53 $ 295.5330%1,386
Joel Greenblatt 2017-12-31 Sold Out 0.05%$199.69 - $247.53 $ 295.5330%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NYSE:EVHC, BKK:BH, NYSE:MD, NYSE:EHC, JSE:LHC, JSE:NTC, NAS:ACHC, NYSE:AMN, ASX:HSO, LSE:MDC, XSGO:BANMEDICA, SAU:4002, NYSE:THC, NYSE:SEM, NAS:LHCG, ASX:SHL, NAS:AMED, NSE:APOLLOHOSP, XTER:RHK, ISX:MIKA » details
Traded in other countries:CXM.Germany,
Headquarter Location:USA
Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services.

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.

Ratios

vs
industry
vs
history
PE Ratio 26.09
CHE's PE Ratio is ranked lower than
76% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 27.31 vs. CHE: 26.09 )
Ranked among companies with meaningful PE Ratio only.
CHE' s PE Ratio Range Over the Past 10 Years
Min: 10.72  Med: 18.24 Max: 53.3
Current: 26.09
10.72
53.3
Forward PE Ratio 24.39
CHE's Forward PE Ratio is ranked lower than
64% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 20.66 vs. CHE: 24.39 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 26.09
CHE's PE Ratio without NRI is ranked lower than
77% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. CHE: 26.09 )
Ranked among companies with meaningful PE Ratio without NRI only.
CHE' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.75  Med: 18.16 Max: 53.3
Current: 26.09
10.75
53.3
Price-to-Owner-Earnings 25.49
CHE's Price-to-Owner-Earnings is ranked lower than
78% of the 109 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. CHE: 25.49 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CHE' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.86  Med: 19.15 Max: 603.86
Current: 25.49
7.86
603.86
PB Ratio 8.48
CHE's PB Ratio is ranked lower than
92% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.64 vs. CHE: 8.48 )
Ranked among companies with meaningful PB Ratio only.
CHE' s PB Ratio Range Over the Past 10 Years
Min: 1.89  Med: 3.07 Max: 10.48
Current: 8.48
1.89
10.48
PS Ratio 2.88
CHE's PS Ratio is ranked lower than
66% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. CHE: 2.88 )
Ranked among companies with meaningful PS Ratio only.
CHE' s PS Ratio Range Over the Past 10 Years
Min: 0.67  Med: 1.12 Max: 3.25
Current: 2.88
0.67
3.25
Price-to-Free-Cash-Flow 40.33
CHE's Price-to-Free-Cash-Flow is ranked lower than
76% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 23.01 vs. CHE: 40.33 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CHE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.1  Med: 15.2 Max: 81.38
Current: 40.33
7.1
81.38
Price-to-Operating-Cash-Flow 27.08
CHE's Price-to-Operating-Cash-Flow is ranked lower than
81% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 14.67 vs. CHE: 27.08 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CHE' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.92  Med: 11.9 Max: 34.86
Current: 27.08
5.92
34.86
EV-to-EBIT 20.94
CHE's EV-to-EBIT is ranked lower than
80% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 21.68 vs. CHE: 20.94 )
Ranked among companies with meaningful EV-to-EBIT only.
CHE' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.2  Med: 10.8 Max: 42.7
Current: 20.94
7.2
42.7
EV-to-EBITDA 18.07
CHE's EV-to-EBITDA is ranked lower than
85% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. CHE: 18.07 )
Ranked among companies with meaningful EV-to-EBITDA only.
CHE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 9 Max: 33.7
Current: 18.07
5.9
33.7
EV-to-Revenue 2.82
CHE's EV-to-Revenue is ranked lower than
58% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. CHE: 2.82 )
Ranked among companies with meaningful EV-to-Revenue only.
CHE' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8  Med: 1.2 Max: 3.4
Current: 2.82
0.8
3.4
PEG Ratio 10.68
CHE's PEG Ratio is ranked lower than
91% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 3.13 vs. CHE: 10.68 )
Ranked among companies with meaningful PEG Ratio only.
CHE' s PEG Ratio Range Over the Past 10 Years
Min: 0.25  Med: 1.48 Max: 29.26
Current: 10.68
0.25
29.26
Shiller PE Ratio 53.62
CHE's Shiller PE Ratio is ranked lower than
69% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 31.76 vs. CHE: 53.62 )
Ranked among companies with meaningful Shiller PE Ratio only.
CHE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.82  Med: 34.34 Max: 63.84
Current: 53.62
22.82
63.84
Current Ratio 1.04
CHE's Current Ratio is ranked lower than
72% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. CHE: 1.04 )
Ranked among companies with meaningful Current Ratio only.
CHE' s Current Ratio Range Over the Past 10 Years
Min: 0.5  Med: 1.22 Max: 2.32
Current: 1.04
0.5
2.32
Quick Ratio 1.01
CHE's Quick Ratio is ranked lower than
68% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. CHE: 1.01 )
Ranked among companies with meaningful Quick Ratio only.
CHE' s Quick Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.07 Max: 2.06
Current: 1.01
0.48
2.06
Days Inventory 1.69
CHE's Days Inventory is ranked higher than
93% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 17.07 vs. CHE: 1.69 )
Ranked among companies with meaningful Days Inventory only.
CHE' s Days Inventory Range Over the Past 10 Years
Min: 1.69  Med: 2.64 Max: 3.3
Current: 1.69
1.69
3.3
Days Sales Outstanding 25.20
CHE's Days Sales Outstanding is ranked higher than
70% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 39.87 vs. CHE: 25.20 )
Ranked among companies with meaningful Days Sales Outstanding only.
CHE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.39  Med: 25.01 Max: 32.21
Current: 25.2
16.39
32.21
Days Payable 14.80
CHE's Days Payable is ranked lower than
81% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 40.58 vs. CHE: 14.80 )
Ranked among companies with meaningful Days Payable only.
CHE' s Days Payable Range Over the Past 10 Years
Min: 12.95  Med: 16.83 Max: 23.78
Current: 14.8
12.95
23.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.39
CHE's Dividend Yield % is ranked lower than
92% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. CHE: 0.39 )
Ranked among companies with meaningful Dividend Yield % only.
CHE' s Dividend Yield % Range Over the Past 10 Years
Min: 0.33  Med: 0.73 Max: 1.2
Current: 0.39
0.33
1.2
Dividend Payout Ratio 0.10
CHE's Dividend Payout Ratio is ranked higher than
92% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 0.43 vs. CHE: 0.10 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CHE' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 0.18
Current: 0.1
0.08
0.18
3-Year Dividend Growth Rate 8.70
CHE's 3-Year Dividend Growth Rate is ranked higher than
51% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 8.70 vs. CHE: 8.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CHE' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -42.4  Med: 2.2 Max: 35.7
Current: 8.7
-42.4
35.7
Forward Dividend Yield % 0.40
CHE's Forward Dividend Yield % is ranked lower than
93% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. CHE: 0.40 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.62
CHE's 5-Year Yield-on-Cost % is ranked lower than
88% of the 325 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. CHE: 0.62 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CHE' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.52  Med: 1.16 Max: 1.91
Current: 0.62
0.52
1.91
3-Year Average Share Buyback Ratio 1.70
CHE's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. CHE: 1.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CHE' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -9.8  Med: 1.4 Max: 6.4
Current: 1.7
-9.8
6.4

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 205.23
CHE's Price-to-Tangible-Book is ranked lower than
100% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 3.33 vs. CHE: 205.23 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CHE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.22  Med: 5.62 Max: 453.4
Current: 205.23
2.22
453.4
Price-to-Intrinsic-Value-Projected-FCF 3.16
CHE's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
71% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. CHE: 3.16 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CHE' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.59  Med: 1.25 Max: 3.44
Current: 3.16
0.59
3.44
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.78
CHE's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
79% of the 33 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. CHE: 1.78 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CHE' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.52  Med: 1.2 Max: 3.17
Current: 1.78
0.52
3.17
Price-to-Median-PS-Value 2.56
CHE's Price-to-Median-PS-Value is ranked lower than
93% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. CHE: 2.56 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CHE' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.28  Med: 0.83 Max: 2.79
Current: 2.56
0.28
2.79
Price-to-Graham-Number 15.44
CHE's Price-to-Graham-Number is ranked lower than
99% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: 2.41 vs. CHE: 15.44 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CHE' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.26  Med: 2.21 Max: 29
Current: 15.44
1.26
29
Earnings Yield (Greenblatt) % 4.77
CHE's Earnings Yield (Greenblatt) % is ranked lower than
63% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. CHE: 4.77 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CHE' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.3  Med: 9.2 Max: 14
Current: 4.77
2.3
14
Forward Rate of Return (Yacktman) % 5.66
CHE's Forward Rate of Return (Yacktman) % is ranked lower than
64% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 9.10 vs. CHE: 5.66 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CHE' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 3.5  Med: 17.55 Max: 28.6
Current: 5.66
3.5
28.6

More Statistics

Revenue (TTM) (Mil) $1,726.79
EPS (TTM) $ 11.32
Beta1.26
Volatility18.48%
52-Week Range $206.80 - 335.99
Shares Outstanding (Mil)16.09

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 1,783 1,878
EBIT (Mil $) 258 296
EBITDA (Mil $) 291 312
EPS ($) 11.45 12.41
EPS without NRI ($) 11.45 12.41
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}